Keystone Symposium: Viral Immunity: Basic Mechanisms and Therapeutic Applications | Poster #: 1040 | A DNA COVID-19 vaccine candidate targeting antigen-presenting cell and adapted to RBD of emerging SARS-CoV-2 variants induced strong cross-neutralizing antibodies and protective immune responses in mice